Jim Cramer says a double developer stock upgrade signals city real estate back

Jim Cramer’s daily rapid fire looks at stocks in the news outside the CNBC Investing Club…

Palo Alto Networks bet big on bundling. Investors want more proof that it’s working

Palo Alto Networks stock has been on a tear into Monday’s fourth-quarter earnings report, entering Friday’s…

Jim Cramer says the best is yet to come at Oracle — plus, his thoughts on 4 more stocks

Jim Cramer’s daily rapid fire looks at stocks in the news outside the CNBC Investing Club…

Jim Cramer says Nike should watch its back with Hoka running shoes doing so well

CNBC’s Jim Cramer sees footwear company Deckers Outdoor as a disruptive industry player that even big…

Here are the portfolio’s top 5 performers in a record-setting week for stocks

The bulls got what they wanted this week: cooler inflation data and record highs. The Dow…

Promise of Eli Lilly’s weight-loss drug for sleep apnea adds another reason to own the stock

Eli Lilly ‘s weight-loss drug Zepbound showed promise as a treatment for sleep apnea — giving…

Health care has had a tough year. Where we stand on our 5 stocks in the sector

There’s Eli Lilly (LLY), and then there’s everybody else. That’s a simple way to describe the…

This health-care stock is set to complete another spin-off. Here’s what it means for our position in the stock

Medical equipment giant Danaher (DHR) will officially spin off its environmental-and-applied solutions segment later this month,…

Activists ease up on Salesforce — plus, 10 other Club stocks traded by Wall Street pros

The extraordinary activist-investor interest in Salesforce (CRM) eased further in the second quarter, according to the…

Here are the 5 price-target changes and 4 trades we made during this busy earnings week

In a jam-packed week of earnings, the Club executed multiple trades and elevated price targets for…

Newseum Global